Skip to main content
. Author manuscript; available in PMC: 2022 Jan 14.
Published in final edited form as: Behav Res Ther. 2021 Oct 6;147:103984. doi: 10.1016/j.brat.2021.103984

Table 1.

Descriptive statistics of outcome measures at all time-points.

Pre-Treatment
Post-Treatment
3MFU
6MFU
M (SD) M (SD) M (SD) M (SD)
SAD composite WL 0.88 (0.84) −0.09 (0.89)
VRE 1.31 (0.61) −0.52 (0.60) −0.45 (0.46) −0.49 (0.77)
SPDQ WL 16.99 (4.42) 12.53 (4.92)
VRE 19.12 (3.50) 9.52 (3.51) 10.10 (2.63) 10.26 (4.30)
SIAS WL 46.45 (14.54) 29.80 (13.28)
VRE 53.48 (9.53) 25.29 (9.50) 25.82 (8.68) 23.95 (12.00)
MASI WL 70.46 (16.27) 47.89 (22.48)
VRE 74.87 (15.80) 38.35 (14.72) 42.21 (12.16) 37.80 (18.08)
PSWQ WL 60.19 (7.81) 47.09 (7.71)
VRE 67.60 (6.92) 46.42 (8.73) 49.01 (10.06) 43.01 (15.12)
PHQ-9 WL 11.20 (6.01) 7.94 (3.60)
VRE 13.20 (5.80) 6.46 (3.11) 7.46 (1.57) 6.22 (4.07)

Note. FU = follow-up; MASI = job interview anxiety scale; PHQ-9 = patient health questionnaire–9-item; PSWQ = Penn State worry questionnaire; SAD composite = averaged standardized score of the social interaction anxiety scale and social phobia diagnostic questionnaire; VRE = virtual reality exposure therapy; WL = waitlist control condition.